Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Antisense oligodeoxynucleotide targeting Bid inhibits bile acid-induced liver injury

Jan. 17, 2002

Hepatitis B vaccine candidate selected in Genencor/Epimmune collaboration

Jan. 16, 2002

Rosiglitazone as a novel therapy for ulcerative colitis

Jan. 16, 2002

Encouraging phase Ia results of XTL-002 in hepatitis C

Jan. 15, 2002

First human trial yields positive data on L-dT, a potential new therapy for HBV

Jan. 11, 2002

Gastric and cholecystokinin receptor ligands claimed in patents by James Black researchers

Jan. 10, 2002

Cell adhesion inhibitor IS-741 effective in rat model of IBD

Jan. 10, 2002

Specific, small-molecule inhibitor of P-selectin with antiinflammatory properties

Jan. 10, 2002

Actimmune enters phase II trial for treatment of liver fibrosis

Jan. 10, 2002

ICN files IND for viramidine

Jan. 9, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...